Principal Analyst, Investor Relations

Additional Location(s): N/A

Diversity - Innovation - Caring - Global Collaboration - Winning Spirit- High Performance

At Boston Scientific, we'll give you the opportunity to harness all that's within you by working in teams of diverse and high-performing employees, tackling some of the most important health industry challenges. With access to the latest tools, information and training, we'll help you in advancing your skills and career. Here, you'll be supported in progressing - whatever your ambitions.

About this role:

The Principal Analyst, Investor Relations, provides analytical and reporting support to the Investor Relations team and senior management, while also providing financial information to external parties, including Wall Street analysts and investors. The successful candidate will be an experienced professional with wide-ranging experience and expertise in the finance and accounting field, with basic understanding of Wall Street roles and functions. The successful candidate will apply comprehensive knowledge of finance and accounting skills to resolve complex issues.

Your responsibilities will include:

• Partneracross the organization (divisional and regional teams, Corporate FP&A, Treasury, Tax, Accounting, and others as necessary) to ensure timeliness, accuracy,and completeness of financial information and general business results for compilation into earnings conference calls, investor conference presentations, responses to investor questions, and responses to other requests for information
• Performdetailed modeling to track Wall Street consensus estimates versus internal Boston Scientific targets
• Leveragedata and external partnerships to provide a quarterly update to senior leadership on stock ownership and targeting activities
• Usein-depth knowledge of business unit functions and cross group dependencies/relationships to best position Boston Scientific externally in communications with Wall Street analysts and investors
• Help create presentations and talking points for senior management, both to internal and external audiences
• Respondto external requests for information from Wall Street analysts and investors
• Partnerwith corporate ESG team to develop and review external messaging and communications
• Providead hoc analysis and information to senior management (e.g., commentary on stock trading activity, competitor stock trading activity, etc.)

Required qualifications:

• Bachelor's degree in Finance, Accounting, or related field
• 6+ years of experience in finance/accounting role or relevant business role
• Strong written and verbal communication, and financial acumen
• Must be able to work well in a complex, highly-matrixed worldwide organization and be able to simplify that matrix for communication and analytical purposes
• Proactive, self-starter, results-oriented, and big picture vision

Preferred Qualifications:

• Full knowledge of Excel and PowerPoint
• Ability to work in fast-paced, demanding environment
• Experience with Bloomberg and/or FactSet
• Experience with Hyperion planning systems

Requisition ID:591276

As a leader in medical science for more than 40 years, we are committed to solving the challenges that matter most - united by a deep caring for human life. Our mission to advance science for life is about transforming lives through innovative medical solutions that improve patient lives, create value for our customers, and support our employees and the communities in which we operate. Now more than ever, we have a responsibility to apply those values to everything we do - as a global business and as a global corporate citizen.

So, choosing a career with Boston Scientific (NYSE: BSX) isn't just business, it's personal. And if you're a natural problem-solver with the imagination, determination, and spirit to make a meaningful difference to people worldwide, we encourage you to apply and look forward to connecting with you!

At Boston Scientific, we recognize that nurturing a diverse and inclusive workplace helps us be more innovative and it is important in our work of advancing science for life and improving patient health. That is why we stand for inclusion, equality, and opportunity for all. By embracing the richness of our unique backgrounds and perspectives, we create a better, more rewarding place for our employees to work and reflect the patients, customers, and communities we serve.

Boston Scientific Corporation has been and will continue to be an equal opportunity employer. To ensure full implementation of its equal employment policy, the Company will continue to take steps to assure that recruitment, hiring, assignment, promotion, compensation, and all other personnel decisions are made and administered without regard to race, religion, color, national origin, citizenship, sex, sexual orientation, gender identify, gender expression, veteran's status, age, mental or physical disability, genetic information or any other protected class.

Boston Scientific maintains a prohibited substance freeworkplace. Pursuant to Va. Code * 2.2-4312 (2000), Boston Scientific is providing notification that the unlawful manufacture, sale, distribution, dispensation, possession, or use of a controlled substance or marijuana is prohibited in the workplace and that violations will result in disciplinary action up to and including termination.

Please be advised that certain US based positions, including without limitation field sales and service positions that call on hospitals and/or health care centers, require acceptable proof of COVID-19 vaccination status. Candidates will be notified during the interview and selection process if the role(s) for which they have applied require proof of vaccination as a condition of employment. Boston Scientific continues to evaluate its policies and protocols regarding the COVID-19 vaccine and will comply with all applicable state and federal law and healthcare credentialing requirements. As employees of the Company, you will be expected to meet the ongoing requirements for your roles, including any new requirements, should the Company's policies or protocols change with regard to COVID-19 vaccination.